ZYBT
NASDAQ
$8.01
Zhengye Biotechnology Holding Ltd (ZYBT)
Zhengye Biotechnology Holding Limited (Ticker: ZYBT) is an innovative biotechnology firm specializing in the development and commercialization of advanced biopharmaceutical products aimed at addressing critical medical needs. With a robust pipeline and proprietary technologies, ZYBT is well-positioned to enhance treatment outcomes across multiple therapeutic areas. The company's commitment to rigorous research and development, coupled with a focus on quality and innovation, underscores its potential for sustainable growth and value creation for investors in the competitive biotechnology landscape.
Sector:
Healthcare
Market Cap
$35M
P/B Ratio
0.92
Free Cash Flow Yield
4.97%
Beta (5Y)
1.00
Price Chart
Valuation
Market Cap$35M
P/S0.30
P/B0.92
Profitability
Total Revenue (TTM)$17M
Gross Profit (TTM)$3.41M
EBITDA-$6.38M
Profit Margin-60%
Operating Margin-60.6%
EPS-$0.21
Financial Health
Debt-to-Equity4.1%
Free Cash Flow Yield4.97%
Growth & Risk
Beta (5Y)1.00
Sharpe Ratio0.89